ARVIX | DOXFX | ARVIX / DOXFX | |
Total Expense Ratio | 0.75 | 0.52 | 144% |
Annual Report Gross Expense Ratio | 0.92 | 0.57 | 161% |
Fund Existence | 4 years | 3 years | - |
Gain YTD | 29.297 | 31.563 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 2500 | 10,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 121M | 60.1B | 0% |
Annual Yield % from dividends | 1.24 | 1.79 | 69% |
Returns for 1 year | 20.89 | 22.47 | 93% |
Returns for 3 years | 87.61 | 73.78 | 119% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FGINX | 16.94 | 0.17 | +1.01% |
Macquarie Growth and Income A | |||
MCSSX | 37.60 | 0.21 | +0.56% |
NYLI WMC Enduring Capital Investor Class | |||
JHDCX | 19.44 | 0.09 | +0.47% |
JPMorgan Hedged Equity 2 C | |||
LIAGX | 17.13 | 0.05 | +0.29% |
Lord Abbett International Growth I | |||
CIAOX | 51.28 | 0.10 | +0.20% |
Capital Advisors Growth Investor |